<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">88044</article-id><article-id pub-id-type="doi">10.7554/eLife.88044</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group><subj-group subj-group-type="heading"><subject>Physics of Living Systems</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Viral Condensates</subject></subj-group></article-categories><title-group><article-title>Making it hard to replicate</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-300010"><name><surname>Ng</surname><given-names>Billy Wai-Lung</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2892-6318</contrib-id><email>billyng@cuhk.edu.hk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Billy Wai-Lung Ng</bold> is in the School of Pharmacy and Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong</p></bio></contrib><contrib contrib-type="author" id="author-315281"><name><surname>Scheeff</surname><given-names>Stephan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7791-9670</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Stephan Scheeff</bold> is in the School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong</p></bio></contrib><contrib contrib-type="author" id="author-315282"><name><surname>Xeque Amada</surname><given-names>Josefina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0008-6847-7725</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Josefina Xeque Amada</bold> is in the School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong</p></bio></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t33hh48</institution-id><institution>The Chinese University of Hong Kong</institution></institution-wrap><addr-line><named-content content-type="city">Hong Kong</named-content></addr-line><country>Hong Kong</country></aff></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>28</day><month>04</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e88044</elocation-id><permissions><copyright-statement>© 2023, Ng et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Ng et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-88044-v1.pdf"/><related-article related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.7554/eLife.85182" id="ra1"/><abstract><p>Understanding how to harden liquid condensates produced by influenza A virus could accelerate the development of novel antiviral drugs.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>biomolecular condensates</kwd><kwd>influenza A virus</kwd><kwd>proteome-wide solubility</kwd><kwd>viral inclusions</kwd><kwd>phase transitions</kwd><kwd>viral condensates</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd><kwd>Viruses</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Understanding how to harden liquid condensates produced by influenza A virus could accelerate the development of novel antiviral drugs.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Etibor TA, Vale-Costa S, Sridharan S, Brás D, Becher I, Mello VH, Ferreira F, Alenquer M, Savitski MM, Amorim MJ. 2023. Defining basic rules for hardening influenza A virus liquid condensates. <italic>eLife</italic> <bold>12</bold>:e85182. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.85182">10.7554/eLife.85182</ext-link>.</p></boxed-text><p>Understanding how viruses infect cells, replicate, and subsequently spread through the body is crucial for developing effective antiviral therapies. During this process, most common viruses – including the one responsible for flu, influenza A virus – form membrane-less organelles called condensates which help the virus to assemble its genome and replicate (<xref ref-type="bibr" rid="bib6">Li et al., 2022</xref>). While some small molecules can manipulate the properties of these condensates to prevent viruses from replicating (<xref ref-type="bibr" rid="bib8">Risso-Ballester et al., 2021</xref>), more research is required to understand how to efficiently and specifically target selected condensates.</p><p>Influenza A virus is thought to induce condensates in order to help with genome assembly (<xref ref-type="bibr" rid="bib1">Alenquer et al., 2019</xref>). Its genome comprises of eight RNA segments, each forming a viral ribonucleoprotein (vRNP) complex that is synthesized in the nucleus. Once formed, the vRNPs migrate to the cytosol where, with a host factor called Rab11a, they create condensates known as viral inclusions, which possess liquid-like properties (<xref ref-type="bibr" rid="bib7">Noda and Kawaoka, 2010</xref>; <xref ref-type="bibr" rid="bib4">Han et al., 2021</xref>). Now, in eLife, Maria João Amorim and colleagues – including Temitope Akhigbe Etibor as first author – report how the material properties of these viral inclusions are maintained and regulated in live cells infected with influenza A virus (<xref ref-type="bibr" rid="bib3">Etibor et al., 2023</xref>).</p><p>The team (who are based at Instituto Gulbenkian de Ciência, European Molecular Biology Laboratory and Católica Biomedical Research Centre) monitored the structure and orientation of viral inclusions by measuring their number, shape, size, and density. How the inclusions moved and interacted with each other was also studied through live-cell imaging and by calculating their molecular stability (<xref ref-type="bibr" rid="bib2">Banani et al., 2017</xref>). Etibor et al. then investigated the impact of different factors on the material properties of the viral inclusions, including temperature, the concentration of vRNPs and Rab11a, and the number and strength of interactions between vRNPs (<xref ref-type="fig" rid="fig1">Figure 1</xref>). This allowed them to determine which of these factors has the greatest effect, and how these pathways may be manipulated to develop a new antiviral approach.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Modulating the material properties of the viral inclusions formed by influenza A virus.</title><p>During infection, influenza A virus (red) enters host cells (blue) and replicates. To achieve this, two driving factors – viral ribonucleoproteins (vRNPs) and a protein called Rab11a – drive the formation of liquid condensates called viral inclusions (top middle inset). It is thought that hardening these viral inclusions (bottom middle inset) so that they become stiffer and less round will make it more difficult for viruses to replicate and assemble their genomes. Etibor et al. investigated how changes in temperature, the concentration of the driving factors, and the valency (i.e., the number/types of interactions among the vRNPs) affected the properties of influenza A virus inclusions. Raising the temperature and concentration of driving factors led to smaller and larger viral inclusions respectively, but had no effect on the material properties of the viral inclusions (top and middle right inset). Increasing the valency led to more rigid viral inclusions, which were unable to fuse together and lost many of their liquid characteristics (bottom right inset).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88044-fig1-v1.tif"/><attrib>Image credit: Figure created with BioRender.</attrib></fig><p>The experiments revealed that while changes in temperature and the concentration of vRNPs and Rab11a altered the size of the viral inclusions, the material properties of the inclusions remained mostly the same. These results are surprising as previous studies have shown that, in general, condensates strongly depend on these two factors. Etibor et al. noted that these findings may be specific to influenza A virus, as its condensates need to maintain liquid-like properties over a wide range of vRNP concentrations to replicate efficiently.</p><p>Next, Etibor et al. treated cells with nucleozin, a pharmacological modulator that has been shown to lower the viral load in patients with influenza A in preclinical studies (<xref ref-type="bibr" rid="bib5">Kao et al., 2010</xref>). Nucleozin glues together nucleoproteins (the major components of vRNPs), expanding the number and type of interactions within individual vRNPs as well as between different complexes. The increased interactions stabilized the vRNPs and led to more rigid and less dynamic viral inclusions which did not dissolve following shock treatments and were less able to fuse together. This suggests that nucleozin hardens the material properties of viral inclusions by increasing interactions between vRNPs.</p><p>The team also showed that nucleozin stiffened viral inclusions in the lung cells of mice infected with influenza A virus, and helped speed up the mice’s recovery. Furthermore, nucleozin did not alter the level of other proteins in the cells of the mice, demonstrating the drug’s specificity against the virus.</p><p>In summary, Etibor et al. revealed how different factors influence the material properties of viral inclusions in both cells and mice infected with influenza A virus. Their findings suggest that stabilizing vRNP interactions shows the most promise for disrupting the function of viral inclusions, and highlight the potential of antiviral drugs that harden these condensates.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alenquer</surname><given-names>M</given-names></name><name><surname>Vale-Costa</surname><given-names>S</given-names></name><name><surname>Etibor</surname><given-names>TA</given-names></name><name><surname>Ferreira</surname><given-names>F</given-names></name><name><surname>Sousa</surname><given-names>AL</given-names></name><name><surname>Amorim</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Influenza A virus ribonucleoproteins form liquid organelles at endoplasmic reticulum exit sites</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1629</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09549-4</pub-id><pub-id pub-id-type="pmid">30967547</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banani</surname><given-names>SF</given-names></name><name><surname>Lee</surname><given-names>HO</given-names></name><name><surname>Hyman</surname><given-names>AA</given-names></name><name><surname>Rosen</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Biomolecular condensates: organizers of cellular biochemistry</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>18</volume><fpage>285</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.7</pub-id><pub-id pub-id-type="pmid">28225081</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etibor</surname><given-names>TA</given-names></name><name><surname>Vale-Costa</surname><given-names>S</given-names></name><name><surname>Sridharan</surname><given-names>S</given-names></name><name><surname>Brás</surname><given-names>D</given-names></name><name><surname>Becher</surname><given-names>I</given-names></name><name><surname>Mello</surname><given-names>VH</given-names></name><name><surname>Ferreira</surname><given-names>F</given-names></name><name><surname>Alenquer</surname><given-names>M</given-names></name><name><surname>Savitski</surname><given-names>MM</given-names></name><name><surname>Amorim</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Defining basic rules for hardening influenza A virus liquid condensates</article-title><source>eLife</source><volume>12</volume><elocation-id>e85182</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.85182</pub-id><pub-id pub-id-type="pmid">37013374</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Ganti</surname><given-names>K</given-names></name><name><surname>Sali</surname><given-names>VK</given-names></name><name><surname>Twigg</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Manivasagam</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>C-Y</given-names></name><name><surname>Vogel</surname><given-names>OA</given-names></name><name><surname>Huang</surname><given-names>I</given-names></name><name><surname>Emmanuel</surname><given-names>SN</given-names></name><name><surname>Plung</surname><given-names>J</given-names></name><name><surname>Radoshevich</surname><given-names>L</given-names></name><name><surname>Perez</surname><given-names>JT</given-names></name><name><surname>Lowen</surname><given-names>AC</given-names></name><name><surname>Manicassamy</surname><given-names>B</given-names></name><name><surname>Shih</surname><given-names>S-R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Host factor Rab11a is critical for efficient assembly of influenza A virus genomic segments</article-title><source>PLOS Pathogens</source><volume>17</volume><elocation-id>e1009517</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009517</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>RY</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Lau</surname><given-names>LS</given-names></name><name><surname>Tsui</surname><given-names>WHW</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>MP</given-names></name><name><surname>Chan</surname><given-names>CM</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Zheng</surname><given-names>BJ</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>JD</given-names></name><name><surname>Madar</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Identification of influenza A nucleoprotein as an antiviral target</article-title><source>Nature Biotechnology</source><volume>28</volume><fpage>600</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1038/nbt.1638</pub-id><pub-id pub-id-type="pmid">20512121</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Ernst</surname><given-names>C</given-names></name><name><surname>Kolonko-Adamska</surname><given-names>M</given-names></name><name><surname>Greb-Markiewicz</surname><given-names>B</given-names></name><name><surname>Man</surname><given-names>J</given-names></name><name><surname>Parissi</surname><given-names>V</given-names></name><name><surname>Ng</surname><given-names>BW-L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Phase separation in viral infections</article-title><source>Trends in Microbiology</source><volume>30</volume><fpage>1217</fpage><lpage>1231</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2022.06.005</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noda</surname><given-names>T</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Structure of influenza virus ribonucleoprotein complexes and their packaging into virions</article-title><source>Reviews in Medical Virology</source><volume>20</volume><fpage>380</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1002/rmv.666</pub-id><pub-id pub-id-type="pmid">20853340</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risso-Ballester</surname><given-names>J</given-names></name><name><surname>Galloux</surname><given-names>M</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Le Goffic</surname><given-names>R</given-names></name><name><surname>Hontonnou</surname><given-names>F</given-names></name><name><surname>Jobart-Malfait</surname><given-names>A</given-names></name><name><surname>Desquesnes</surname><given-names>A</given-names></name><name><surname>Sake</surname><given-names>SM</given-names></name><name><surname>Haid</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Rincheval</surname><given-names>V</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Pietschmann</surname><given-names>T</given-names></name><name><surname>Eléouët</surname><given-names>JF</given-names></name><name><surname>Rameix-Welti</surname><given-names>MA</given-names></name><name><surname>Altmeyer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A condensate-hardening drug blocks RSV replication in vivo</article-title><source>Nature</source><volume>595</volume><fpage>596</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03703-z</pub-id><pub-id pub-id-type="pmid">34234347</pub-id></element-citation></ref></ref-list></back></article>